RaySearch Laboratories AB (publ), a medical technology company, provides software solutions for cancer care in the Americas, Europe, Africa, the Asia-Pacific, and the Middle East. It develops and markets RayStation, a treatment planning system for radiation therapy; RayCare, an oncology information system that manages clinical activities; RayIntelligence, a cloud-based analytics system for monitoring and enhancement of cancer therapy; and RayCommand, a treatment control system that serves as link between the treatment machine and the treatment planning and oncology information systems. The company offers RayPlan, a treatment planning system for supporting a range of treatment planning activities for 3D-CRT, IMRT, VMAT, and electron beam radiation therapy; and µ-RayStation, a software platform for planning and evaluation in small animal irradiation research. The company (publ) was incorporated in 1988 and is headquartered in Stockholm, Sweden.
Metrics to compare | 0GRZ | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship0GRZPeersSector | |
---|---|---|---|---|
P/E Ratio | 45.2x | 9.0x | −0.7x | |
PEG Ratio | 0.26 | 0.03 | 0.00 | |
Price/Book | 9.8x | 4.0x | 2.6x | |
Price / LTM Sales | 6.8x | 1.9x | 3.1x | |
Upside (Analyst Target) | - | 22.7% | 49.0% | |
Fair Value Upside | Unlock | 13.0% | 7.4% | Unlock |